UFP Technologies to Present and Host 1X1 Investor Meetings at the Raymond James 47th Annual Institutional Investors Conference
Rhea-AI Summary
UFP Technologies (Nasdaq: UFPT) will present and host 1x1 investor meetings at the Raymond James 47th Annual Institutional Investors Conference in Orlando, March 1-4, 2026. Chairman & CEO R. Jeffrey Bailly and CFO Ron Lataille will present on March 3, 2026 at 2:50 PM ET. A live webcast of the presentation will be available.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
UFPT fell 10.2% while peers were mixed: CNMD -0.89%, but ENOV +12.38%, IART +6.69%, NVCR +3.76%, AORT +7.36%. With no peers in the momentum scanner, the move appears stock-specific rather than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| 2026-02-24 | Full-year results | Positive | -0.2% | Record 2025 net sales and earnings growth highlighted across medical segment. |
| 2026-02-19 | Earnings date set | Neutral | -9.4% | Announced timing for Q4 and full-year 2025 results and conference call. |
| 2025-12-02 | CEO succession plan | Neutral | -1.1% | Planned 2026 CEO transition with outgoing leader moving to Executive Chairman. |
| 2025-11-25 | Conference appearance | Neutral | -2.2% | Planned presentation and 1x1 meetings at a major healthcare investor conference. |
| 2025-11-03 | Q3 2025 earnings | Positive | +12.1% | Strong Q3 2025 sales and earnings with robust medical market growth. |
Recent news often saw muted or negative price reactions, even to objectively strong financial results, with only one clear positive earnings reaction aligning with the news.
Over the last few months, UFPT has reported multiple milestones. Record 2025 results on Feb 24, 2026 and strong Q3 2025 results on Nov 3, 2025 highlighted growth in medical sales and rising earnings, yet the record 2025 report saw a slight -0.17% move while Q3 earnings gained 12.05%. CEO succession was announced on Dec 2, 2025, and prior conference participation on Nov 25, 2025 led to a -2.21% move. Today’s conference-related announcement fits a pattern where neutral news has sometimes coincided with notable downside.
Market Pulse Summary
This announcement highlights UFPT’s engagement with institutional investors via a presentation and 1x1 meetings at a major conference from March 1–4, 2026. It follows record 2025 financial results and a planned CEO transition, as detailed in prior disclosures and 8-K filings. Investors may monitor how management frames recent growth in medical markets, contract extensions, and cybersecurity remediation efforts, as well as how the stock trades relative to its 200-day MA $227.16 and 52-week range after the event.
AI-generated analysis. Not financial advice.
NEWBURYPORT, Mass., Feb. 27, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming Raymond James 47th Annual Institutional Investors Conference to be held in Orlando, Florida March 1-4, 2026. UFP’s presentation is scheduled to begin at 2:50 PM on Tuesday, March 3rd. A live webcast of UFP’s presentation will be available here.
About UFP Technologies, Inc.
UFP Technologies is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. UFP is a vital link in the medical device supply chain and a valued outsourcing partner to many of the world's top medical device manufacturers. The Company’s single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.
Contacts:
Ron Lataille, CFO, UFP Technologies, Inc., tel. 978-234-0926
rlataille@ufpt.com
Jeff Elliott, Three Part Advisors, LLC, tel. 214-966-9014
jelliott@threepa.com